TP53 and prostate carcinoma: The incidence of TP53 mutations in primary prostate cancer has been reported as much lower than other carcinomas such as pancreatic, ovarian, breast or colon cancers, with higher frequencies detected in prostate cancer metastatic samples31, though these results have been disputed32.